0
     

Report Added
Report already added
Chronic Kidney Disease (CKD) Market - Global Outlook and Forecast 2022-2028

Chronic Kidney Disease (CKD) Market - Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Chronic Kidney Disease (CKD) in Global, including the following market information:

Global Chronic Kidney Disease (CKD) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Chronic Kidney Disease (CKD) market was valued at 91100 million in 2021 and is projected to reach US$ 113470 million by 2028, at a CAGR of 3.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ACE Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chronic Kidney Disease (CKD) include AbbVie, Allergan, Amgen, AstraZeneca, Roche, FibroGen, GlaxoSmithKline, Johnson & Johnson and Keryx, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Kidney Disease (CKD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Chronic Kidney Disease (CKD) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Chronic Kidney Disease (CKD) Market Segment Percentages, by Type, 2021 (%)
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others
Global Chronic Kidney Disease (CKD) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Chronic Kidney Disease (CKD) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Global Chronic Kidney Disease (CKD) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Chronic Kidney Disease (CKD) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Kidney Disease (CKD) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Chronic Kidney Disease (CKD) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Allergan
Amgen
AstraZeneca
Roche
FibroGen
GlaxoSmithKline
Johnson & Johnson
Keryx
Kissei
Pfizer
Sanofi
Teva
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Chronic Kidney Disease (CKD) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Kidney Disease (CKD) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Kidney Disease (CKD) Overall Market Size
2.1 Global Chronic Kidney Disease (CKD) Market Size: 2021 VS 2028
2.2 Global Chronic Kidney Disease (CKD) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chronic Kidney Disease (CKD) Players in Global Market
3.2 Top Global Chronic Kidney Disease (CKD) Companies Ranked by Revenue
3.3 Global Chronic Kidney Disease (CKD) Revenue by Companies
3.4 Top 3 and Top 5 Chronic Kidney Disease (CKD) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Chronic Kidney Disease (CKD) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chronic Kidney Disease (CKD) Players in Global Market
3.6.1 List of Global Tier 1 Chronic Kidney Disease (CKD) Companies
3.6.2 List of Global Tier 2 and Tier 3 Chronic Kidney Disease (CKD) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Chronic Kidney Disease (CKD) Market Size Markets, 2021 & 2028
4.1.2 ACE Inhibitors
4.1.3 Calcium Channel Blockers
4.1.4 Beta Blockers
4.1.5 Others
4.2 By Type - Global Chronic Kidney Disease (CKD) Revenue & Forecasts
4.2.1 By Type - Global Chronic Kidney Disease (CKD) Revenue, 2017-2022
4.2.2 By Type - Global Chronic Kidney Disease (CKD) Revenue, 2023-2028
4.2.3 By Type - Global Chronic Kidney Disease (CKD) Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chronic Kidney Disease (CKD) Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.2 By Application - Global Chronic Kidney Disease (CKD) Revenue & Forecasts
5.2.1 By Application - Global Chronic Kidney Disease (CKD) Revenue, 2017-2022
5.2.2 By Application - Global Chronic Kidney Disease (CKD) Revenue, 2023-2028
5.2.3 By Application - Global Chronic Kidney Disease (CKD) Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Chronic Kidney Disease (CKD) Market Size, 2021 & 2028
6.2 By Region - Global Chronic Kidney Disease (CKD) Revenue & Forecasts
6.2.1 By Region - Global Chronic Kidney Disease (CKD) Revenue, 2017-2022
6.2.2 By Region - Global Chronic Kidney Disease (CKD) Revenue, 2023-2028
6.2.3 By Region - Global Chronic Kidney Disease (CKD) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Chronic Kidney Disease (CKD) Revenue, 2017-2028
6.3.2 US Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.3.3 Canada Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.3.4 Mexico Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Chronic Kidney Disease (CKD) Revenue, 2017-2028
6.4.2 Germany Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.4.3 France Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.4.4 U.K. Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.4.5 Italy Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.4.6 Russia Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.4.7 Nordic Countries Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.4.8 Benelux Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Chronic Kidney Disease (CKD) Revenue, 2017-2028
6.5.2 China Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.5.3 Japan Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.5.4 South Korea Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.5.5 Southeast Asia Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.5.6 India Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Chronic Kidney Disease (CKD) Revenue, 2017-2028
6.6.2 Brazil Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.6.3 Argentina Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chronic Kidney Disease (CKD) Revenue, 2017-2028
6.7.2 Turkey Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.7.3 Israel Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.7.4 Saudi Arabia Chronic Kidney Disease (CKD) Market Size, 2017-2028
6.7.5 UAE Chronic Kidney Disease (CKD) Market Size, 2017-2028
7 Players Profiles
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Chronic Kidney Disease (CKD) Major Product Offerings
7.1.4 AbbVie Chronic Kidney Disease (CKD) Revenue in Global Market (2017-2022)
7.1.5 AbbVie Key News
7.2 Allergan
7.2.1 Allergan Corporate Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Chronic Kidney Disease (CKD) Major Product Offerings
7.2.4 Allergan Chronic Kidney Disease (CKD) Revenue in Global Market (2017-2022)
7.2.5 Allergan Key News
7.3 Amgen
7.3.1 Amgen Corporate Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Chronic Kidney Disease (CKD) Major Product Offerings
7.3.4 Amgen Chronic Kidney Disease (CKD) Revenue in Global Market (2017-2022)
7.3.5 Amgen Key News
7.4 AstraZeneca
7.4.1 AstraZeneca Corporate Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Chronic Kidney Disease (CKD) Major Product Offerings
7.4.4 AstraZeneca Chronic Kidney Disease (CKD) Revenue in Global Market (2017-2022)
7.4.5 AstraZeneca Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Chronic Kidney Disease (CKD) Major Product Offerings
7.5.4 Roche Chronic Kidney Disease (CKD) Revenue in Global Market (2017-2022)
7.5.5 Roche Key News
7.6 FibroGen
7.6.1 FibroGen Corporate Summary
7.6.2 FibroGen Business Overview
7.6.3 FibroGen Chronic Kidney Disease (CKD) Major Product Offerings
7.6.4 FibroGen Chronic Kidney Disease (CKD) Revenue in Global Market (2017-2022)
7.6.5 FibroGen Key News
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Corporate Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Chronic Kidney Disease (CKD) Major Product Offerings
7.7.4 GlaxoSmithKline Chronic Kidney Disease (CKD) Revenue in Global Market (2017-2022)
7.7.5 GlaxoSmithKline Key News
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Corporate Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Chronic Kidney Disease (CKD) Major Product Offerings
7.8.4 Johnson & Johnson Chronic Kidney Disease (CKD) Revenue in Global Market (2017-2022)
7.8.5 Johnson & Johnson Key News
7.9 Keryx
7.9.1 Keryx Corporate Summary
7.9.2 Keryx Business Overview
7.9.3 Keryx Chronic Kidney Disease (CKD) Major Product Offerings
7.9.4 Keryx Chronic Kidney Disease (CKD) Revenue in Global Market (2017-2022)
7.9.5 Keryx Key News
7.10 Kissei
7.10.1 Kissei Corporate Summary
7.10.2 Kissei Business Overview
7.10.3 Kissei Chronic Kidney Disease (CKD) Major Product Offerings
7.10.4 Kissei Chronic Kidney Disease (CKD) Revenue in Global Market (2017-2022)
7.10.5 Kissei Key News
7.11 Pfizer
7.11.1 Pfizer Corporate Summary
7.11.2 Pfizer Business Overview
7.11.3 Pfizer Chronic Kidney Disease (CKD) Major Product Offerings
7.11.4 Pfizer Chronic Kidney Disease (CKD) Revenue in Global Market (2017-2022)
7.11.5 Pfizer Key News
7.12 Sanofi
7.12.1 Sanofi Corporate Summary
7.12.2 Sanofi Business Overview
7.12.3 Sanofi Chronic Kidney Disease (CKD) Major Product Offerings
7.12.4 Sanofi Chronic Kidney Disease (CKD) Revenue in Global Market (2017-2022)
7.12.5 Sanofi Key News
7.13 Teva
7.13.1 Teva Corporate Summary
7.13.2 Teva Business Overview
7.13.3 Teva Chronic Kidney Disease (CKD) Major Product Offerings
7.13.4 Teva Chronic Kidney Disease (CKD) Revenue in Global Market (2017-2022)
7.13.5 Teva Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Chronic Kidney Disease (CKD) Market Opportunities & Trends in Global Market
Table 2. Chronic Kidney Disease (CKD) Market Drivers in Global Market
Table 3. Chronic Kidney Disease (CKD) Market Restraints in Global Market
Table 4. Key Players of Chronic Kidney Disease (CKD) in Global Market
Table 5. Top Chronic Kidney Disease (CKD) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Chronic Kidney Disease (CKD) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Chronic Kidney Disease (CKD) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Chronic Kidney Disease (CKD) Product Type
Table 9. List of Global Tier 1 Chronic Kidney Disease (CKD) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Kidney Disease (CKD) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Chronic Kidney Disease (CKD) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Chronic Kidney Disease (CKD) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Chronic Kidney Disease (CKD) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Chronic Kidney Disease (CKD) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Chronic Kidney Disease (CKD) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Chronic Kidney Disease (CKD) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Chronic Kidney Disease (CKD) Product Offerings
Table 32. AbbVie Chronic Kidney Disease (CKD) Revenue (US$, Mn), (2017-2022)
Table 33. Allergan Corporate Summary
Table 34. Allergan Chronic Kidney Disease (CKD) Product Offerings
Table 35. Allergan Chronic Kidney Disease (CKD) Revenue (US$, Mn), (2017-2022)
Table 36. Amgen Corporate Summary
Table 37. Amgen Chronic Kidney Disease (CKD) Product Offerings
Table 38. Amgen Chronic Kidney Disease (CKD) Revenue (US$, Mn), (2017-2022)
Table 39. AstraZeneca Corporate Summary
Table 40. AstraZeneca Chronic Kidney Disease (CKD) Product Offerings
Table 41. AstraZeneca Chronic Kidney Disease (CKD) Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Chronic Kidney Disease (CKD) Product Offerings
Table 44. Roche Chronic Kidney Disease (CKD) Revenue (US$, Mn), (2017-2022)
Table 45. FibroGen Corporate Summary
Table 46. FibroGen Chronic Kidney Disease (CKD) Product Offerings
Table 47. FibroGen Chronic Kidney Disease (CKD) Revenue (US$, Mn), (2017-2022)
Table 48. GlaxoSmithKline Corporate Summary
Table 49. GlaxoSmithKline Chronic Kidney Disease (CKD) Product Offerings
Table 50. GlaxoSmithKline Chronic Kidney Disease (CKD) Revenue (US$, Mn), (2017-2022)
Table 51. Johnson & Johnson Corporate Summary
Table 52. Johnson & Johnson Chronic Kidney Disease (CKD) Product Offerings
Table 53. Johnson & Johnson Chronic Kidney Disease (CKD) Revenue (US$, Mn), (2017-2022)
Table 54. Keryx Corporate Summary
Table 55. Keryx Chronic Kidney Disease (CKD) Product Offerings
Table 56. Keryx Chronic Kidney Disease (CKD) Revenue (US$, Mn), (2017-2022)
Table 57. Kissei Corporate Summary
Table 58. Kissei Chronic Kidney Disease (CKD) Product Offerings
Table 59. Kissei Chronic Kidney Disease (CKD) Revenue (US$, Mn), (2017-2022)
Table 60. Pfizer Corporate Summary
Table 61. Pfizer Chronic Kidney Disease (CKD) Product Offerings
Table 62. Pfizer Chronic Kidney Disease (CKD) Revenue (US$, Mn), (2017-2022)
Table 63. Sanofi Corporate Summary
Table 64. Sanofi Chronic Kidney Disease (CKD) Product Offerings
Table 65. Sanofi Chronic Kidney Disease (CKD) Revenue (US$, Mn), (2017-2022)
Table 66. Teva Corporate Summary
Table 67. Teva Chronic Kidney Disease (CKD) Product Offerings
Table 68. Teva Chronic Kidney Disease (CKD) Revenue (US$, Mn), (2017-2022)

List of Figures
Figure 1. Chronic Kidney Disease (CKD) Segment by Type in 2021
Figure 2. Chronic Kidney Disease (CKD) Segment by Application in 2021
Figure 3. Global Chronic Kidney Disease (CKD) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Chronic Kidney Disease (CKD) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Chronic Kidney Disease (CKD) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chronic Kidney Disease (CKD) Revenue in 2021
Figure 8. By Type - Global Chronic Kidney Disease (CKD) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Chronic Kidney Disease (CKD) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Chronic Kidney Disease (CKD) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Chronic Kidney Disease (CKD) Revenue Market Share, 2017-2028
Figure 12. US Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Chronic Kidney Disease (CKD) Revenue Market Share, 2017-2028
Figure 16. Germany Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 17. France Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Chronic Kidney Disease (CKD) Revenue Market Share, 2017-2028
Figure 24. China Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 28. India Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Chronic Kidney Disease (CKD) Revenue Market Share, 2017-2028
Figure 30. Brazil Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Chronic Kidney Disease (CKD) Revenue Market Share, 2017-2028
Figure 33. Turkey Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Chronic Kidney Disease (CKD) Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allergan Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Amgen Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AstraZeneca Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. FibroGen Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GlaxoSmithKline Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Johnson & Johnson Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Keryx Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Kissei Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Pfizer Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Sanofi Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Teva Chronic Kidney Disease (CKD) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Report Title: Chronic Kidney Disease (CKD) Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027

Cell Therapy Technologies Market by Product (Media, Sera & Reagents, Cell Culture Vessels, Single Use Equipment, Systems & Software), Process (Cell Processing), Cell Type (T-cells, Stem Cells), End User (Biopharma, CMOs), Region - Global Forecast to 2027

Cell Therapy Technologies Market by Product (Media, Sera & Reagents, Cell Culture Vessels, Single Use Equipment, Systems & Software), Process (Cell Processing), Cell Type (T-cells, Stem Cells), End User (Biopharma, CMOs), Region - Global Forecast to 2027

Theranos Scandal - Silicon Valley Scandal Indicative of the Current Investment Culture

Theranos Scandal - Silicon Valley Scandal Indicative of the Current Investment Culture